BMJ Open (Jul 2021)

SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study

  • Gilbert Greub,
  • Giuseppe Pantaleo,
  • Oriol Manuel,
  • Urania Dafni,
  • Valérie D'Acremont,
  • Estelle Moulin,
  • Bruno Grandbastien,
  • Thierry Calandra,
  • Sylvain Meylan,
  • Frederic Lamoth,
  • Zoi Tsourti,
  • Michael A Lobritz,
  • Jean Regina,
  • Philippe Bressin,
  • Laurence Senn,
  • Cyril Andre,
  • Craig Fenwick,
  • Antony Croxatto,
  • Isabelle Guilleret,
  • Catherine Lazor-Blanchet,
  • Oliver Peters,
  • Michael Currat,
  • Laurence Posset,
  • Fady Fares,
  • Vassili Soumas,
  • Séverine Bignon,
  • Elisa Corne,
  • Joana Da Silva Quelhas,
  • Allan Dussex,
  • Dominique Ker,
  • Patricia Mosset,
  • Eugénie Prouvost,
  • Kyllian Ruscio,
  • Sandrine Piccon,
  • Fleur Valterio,
  • Emilie Allain,
  • Charles Guay,
  • Zahra Hezari,
  • Yoann Levet,
  • Marie-Agnès Prevost,
  • Adeline Rognon,
  • Homa Salehi-Gysel,
  • Cécile Starck,
  • Aurélie Tornier,
  • Sara Torres da Fonseca,
  • Aline Udriot

DOI
https://doi.org/10.1136/bmjopen-2021-049232
Journal volume & issue
Vol. 11, no. 7

Abstract

Read online

Objective To assess the SARS-CoV-2 transmission in healthcare workers (HCWs) using seroprevalence as a surrogate marker of infection in our tertiary care centre according to exposure.Design Seroprevalence cross-sectional study.Setting Single centre at the end of the first COVID-19 wave in Lausanne, Switzerland.Participants 1874 of 4074 responders randomly selected (46% response rate), stratified by work category among the 13 474 (13.9%) HCWs.Main outcome measures Evaluation of SARS-CoV-2 serostatus paired with a questionnaire of SARS-CoV-2 acquisition risk factors internal and external to the workplace.Results The overall SARS-CoV-2 seroprevalence rate among HCWs was 10.0% (95% CI 8.7% to 11.5%). HCWs with daily patient contact did not experience increased rates of seropositivity relative to those without (10.3% vs 9.6%, respectively, p=0.64). HCWs with direct contact with patients with COVID-19 or working in COVID-19 units did not experience increased seropositivity rates relative to their counterparts (10.4% vs 9.8%, p=0.69 and 10.6% vs 9.9%, p=0.69, respectively). However, specific locations of contact with patients irrespective of COVID-19 status—in patient rooms or reception areas—did correlate with increased rates of seropositivity (11.9% vs 7.5%, p=0.019 and 14.3% vs 9.2%, p=0.025, respectively). In contrast, HCWs with a suspected or proven SARS-CoV-2-infected household contact had significantly higher seropositivity rates than those without such contacts (19.0% vs 8.7%, p<0.001 and 42.1% vs 9.4%, p<0.001, respectively). Finally, consistent use of a mask on public transportation correlated with decreased seroprevalence (5.3% for mask users vs 11.2% for intermittent or no mask use, p=0.030).Conclusions The overall seroprevalence was 10% without significant differences in seroprevalence between HCWs exposed to patients with COVID-19 and HCWs not exposed. This suggests that, once fully in place, protective measures limited SARS-CoV-2 occupational acquisition within the hospital environment. SARS-CoV-2 seroconversion among HCWs was associated primarily with community risk factors, particularly household transmission.